The clinical performance is complex and often involves multiple systems. Early identification and standardization of the diagnosis is essential for improving the prognosis. The diagnosis of the disease needs to be combined with a comprehensive assessment of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in matching authoritative experts and teams at home and abroad to provide accurate diagnosis and treatment plans. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immunodeficiency disorders that were previously difficult to treat have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the course of treatment.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of the common type of asthma. The platform serves the China International Medical Service System, a team of internationally authoritative experts in the field of autoimmune and rheumatic immunity, to provide the following services to patients: Remote pre-diagnosis: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.